Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2991821000168114 | Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2991831000168112 | Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 1 x 50 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | Is a | prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 50 mL vial | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | has TPUU | Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | true | Inferred relationship | Some | 1 | |
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | has TP | Citanest | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | Is a | True | Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR